[Cardiac involvement at rest in patients with systemic sclerosis: differences between the limited and the diffuse

Giornale Italiano Di Cardiologia (2006)
|February 8, 2014
PubMed

Insights

Cardiac involvement is more common and appears earlier in patients with diffuse systemic sclerosis (dcSSc) compared to limited systemic sclerosis (lcSSc). This study highlights key differences in heart disease progression between these systemic sclerosis subtypes.

Area of Science:

  • Cardiology
  • Rheumatology
  • Systemic Sclerosis Research

Context:

  • Heart involvement in systemic sclerosis (SSc) is linked to poor prognosis.
  • The prevalence and specific manifestations of cardiac involvement in SSc subtypes remain incompletely understood.
  • Understanding these differences is crucial for patient management and prognosis.

Purpose:

  • To investigate the prevalence of common resting heart abnormalities in patients with systemic sclerosis (SSc).
  • To compare the frequency of cardiac manifestations between diffuse cutaneous systemic sclerosis (dcSSc) and limited cutaneous systemic sclerosis (lcSSc) subtypes.
  • To analyze the influence of disease duration on cardiac involvement in SSc.

Summary:

  • This study evaluated 174 SSc patients using electrocardiography and echocardiography.
  • Diffuse cutaneous SSc (dcSSc) patients exhibited a higher prevalence of heart involvement, including conduction and valvular abnormalities, particularly within the first 5-10 years post-Raynaud's phenomenon onset.
  • Rhythm disturbances and left ventricular hypertrophy were also more prevalent in dcSSc, especially with longer disease durations.

Impact:

  • Findings indicate that cardiac manifestations develop earlier and are more frequent in dcSSc patients compared to lcSSc patients.
  • This research provides valuable insights into the differential progression of cardiac disease in SSc subtypes.
  • Early identification and monitoring of cardiac involvement in dcSSc are essential for improving patient outcomes.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620